Anthem Biosciences Limited (ANTHEM) Financial Statements

5 Followers

Anthem Biosciences Limited Financial Overview

Anthem Biosciences Limited's market cap is currently ₹428.08B. The company's EPS TTM is ₹4.57; its P/E ratio is 72.09; Anthem Biosciences Limited is scheduled to report earnings on May 19, 2026, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 26	Mar 25
Income Statement
Total Revenue	₹ 21.24B	₹ 18.45B
Gross Profit	₹ 8.95B	₹ 11.01B
Operating Income	₹ 7.00B	₹ 5.92B
EBITDA	₹ 8.34B	₹ 7.56B
Net Income	₹ 5.92B	₹ 4.51B
Balance Sheet
Cash & Short-Term Investments	₹ 9.40B	₹ 7.32B
Total Assets	₹ 34.29B	₹ 28.08B
Total Debt	₹ 539.24M	₹ 1.13B
Net Debt	₹ -2.21B	₹ -2.03B
Total Liabilities	₹ 3.87B	₹ 3.98B
Stockholders' Equity	₹ 30.43B	₹ 24.10B
Cash Flow
Free Cash Flow	₹ 7.06B	₹ 1.04B
Operating Cash Flow	₹ 9.17B	₹ 4.18B
Investing Cash Flow	₹ -7.81B	₹ -1.52B
Financing Cash Flow	₹ -331.04M	₹ -1.34B

Currency in INR

Anthem Biosciences Limited Earnings and Revenue History

Income Statement >

Anthem Biosciences Limited Debt to Assets

Balance Sheet >

Anthem Biosciences Limited Cash Flow

Cash Flow >

Anthem Biosciences Limited Forecast EPS vs Actual EPS

Earnings >